Company Filing History:
Years Active: 2017-2022
Title: Innovations by Inventor Yang Lee
Introduction
Yang Lee is an accomplished inventor based in San Diego, CA. She has made significant contributions to the field of cancer treatment through her innovative work on arginine deiminase proteins. With a total of 2 patents, her research focuses on enhancing the efficacy of treatments for arginine-dependent diseases.
Latest Patents
Yang Lee's latest patents include advancements in arginine deiminase with reduced cross-reactivity toward ADI-PEG 20 antibodies for cancer treatment. The present invention relates to isolated arginine deiminase (ADI) proteins that exhibit reduced cross-reactivity with anti-ADI-PEG 20 antibodies compared to ADI-PEG 20. These proteins maintain functional characteristics that are comparable to or better than ADI-PEG 20. The compositions comprising these ADI proteins are aimed at treating arginine-dependent diseases, including various forms of cancer.
Career Highlights
Throughout her career, Yang Lee has worked with notable companies such as Polaris Group and TDW Group. Her experience in these organizations has contributed to her expertise in the development of innovative treatments.
Collaborations
Yang has collaborated with esteemed colleagues, including Richard E. Showalter and Robert Almassy. These partnerships have further enriched her research and development efforts.
Conclusion
Yang Lee's contributions to the field of cancer treatment through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.